ET
Healthcare & Life Sciences
EnLiven Therapeutics
EnLiven Therapeutics is a Healthcare & Life Sciences startup based in Israel, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About EnLiven Therapeutics
Based in Israel, EnLiven Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
EnLiven Therapeutics is a biopharmaceutical company focused on developing novel therapeutics to treat fibrotic diseases.
Explore EnLiven Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.